The world's largest COVID-19 vaccine drive is set to roll out today across India. The government has activated a systematic and complex logistics and supply chain to take the vaccine from its point of origin to the citizens.
Two vaccines, Covishield and Covaxin, have been approved for restricted emergency use in India. Covishield, developed by Oxford University and AstraZeneca, is being produced by Serum Institute of India, while Bharat Biotech's Covaxin has been indigenously developed.
The first consignment of Covishield reached 13 locations on Tuesday while that of Covaxin reached 11 cities a day later. In the initial phase, 30 crore Indans will get it for free: first, one crore health workers and two crore frontline workers, followed by those above 50 years age and with co-morbid conditions. On Day 1, three lakh health workers will receive the vaccine.